Prediction of clinical response to methylphenidate in children with attention-deficit hyperactivity disorder.
about
Methylphenidate for children and adolescents with attention deficit hyperactivity disorder (ADHD)Influence of methylphenidate on brain development--an update of recent animal experiments.Methylphenidate normalizes resting-state brain dysfunction in boys with attention deficit hyperactivity disorderDifferential brain development with low and high IQ in attention-deficit/hyperactivity disorderSafety of stimulant treatment in attention deficit hyperactivity disorder: part II.What is attention-deficit hyperactivity disorder (ADHD)?Predicting methylphenidate response in long-term survivors of childhood cancer: a randomized, double-blind, placebo-controlled, crossover trialEmerging drugs in Tourette syndrome.Omega-3 fatty acids in ADHD and related neurodevelopmental disorders.Prediction of treatment outcomes in psychiatry--where do we stand ?Pharmacogenetic predictors of methylphenidate dose-response in attention-deficit/hyperactivity disorder.Factors associated with response to methylphenidate in advanced cancer patients.Association between societal costs and treatment response in children and adolescents with ADHD and their parents. A cross-sectional study in the Netherlands.Meditation or Medication? Mindfulness training versus medication in the treatment of childhood ADHD: a randomized controlled trial.Predictors of treatment response in adolescents with comorbid substance use disorder and attention-deficit/hyperactivity disorder.Attention-deficit/hyperactivity disorder: using P300 topography to choose optimal treatment.Neuroimaging-Aided Prediction of the Effect of Methylphenidate in Children with Attention-Deficit Hyperactivity Disorder: A Randomized Controlled Trial.The impact of individual and methodological factors in the variability of response to methylphenidate in ADHD pharmacogenetic studies from four different continentsEffects of maternal symptom ratings and other clinical features on short-term treatment response to OROS methylphenidate in children and adolescents with ADHD in a naturalistic clinical setting.Does EEG-neurofeedback improve neurocognitive functioning in children with attention-deficit/hyperactivity disorder? A systematic review and a double-blind placebo-controlled study.Uses and misuses of treatments for ADHD. The second Birgit Olsson lecture.An evaluation of the pharmacokinetics of methylphenidate for the treatment of attention-deficit/ hyperactivity disorder.Predictors of relapse or maintenance of response in pediatric and adult patients with attention-deficit/hyperactivity disorder following discontinuation of long-term treatment with atomoxetine.Primary Pediatric Care Psychopharmacology: Focus on Medications for ADHD, Depression, and Anxiety.Predictors of Response to Behavioral Treatments Among Children With ADHD-Inattentive Type.Efficacy of Methylphenidate in ADHD Children across the Normal and the Gifted Intellectual SpectrumMeta-Analysis: Reduced Risk of Anxiety with Psychostimulant Treatment in Children with Attention-Deficit/Hyperactivity Disorder.Methylphenidate improves working memory and set-shifting in AD/HD: relationships to baseline memory capacity.[Analysis of methylphenidate's efficacy using the abbreviated version Conners' questionnaire in attention deficit hyperactivity disorder].Comorbid anxiety and neurocognitive dysfunctions in children with ADHD.Predicting response of ADHD symptoms to methylphenidate treatment based on comorbid anxiety.Post Hoc Analysis of Potential Predictors of Response to Atomoxetine for the Treatment of Adults with Attention-Deficit/Hyperactivity Disorder using an Integrated Database.High sibling correlation on methylphenidate response but no association with DAT1-10R homozygosity in Dutch sibpairs with ADHD.Which anxiety disorders may differentiate attention deficit hyperactivity disorder, combined type with dysthymic disorder from attention deficit hyperactivity disorder, combined type alone?Attention deficit hyperactivity disorder: anxiety phenomena in children treated with psychostimulant medication for 6 months or more.Attention deficit hyperactivity disorder and anxiety: is there an association with neurodevelopmental deficits?Predicting stimulant medication response in ADHD: evidence from an integrated profile of neuropsychological, psychophysiological and clinical factors.Attention-deficit/hyperactivity disorder: a neurodevelopmental approach.Predicting methylphenidate response in attention deficit hyperactivity disorder: A preliminary study
P2860
Q22061981-112904AE-DD86-4E9C-AAD0-156F53A2E028Q24537917-2C31437D-1714-4572-A8E0-4197C9396826Q28703539-C352B4F9-B6E5-4942-BA0B-B64AB0DA6E13Q28730440-6FA1071C-639A-4A1A-BD0C-D33C1BF68D4BQ30451303-21ABB276-BE9C-43C9-8A2C-DB8945B4C46CQ33231807-A6A53053-9A3C-4A31-8939-CAED2B7F7498Q33988480-FAB87380-1613-4797-A6E4-ABDAB34658D1Q34423658-B20D92CB-F6C0-4B01-8F41-7F5562489568Q34538615-FAB9974B-9BDD-4893-A0D0-BB767768B42DQ35109159-64F34419-51CE-45D5-9ADD-A0669FE26A8EQ35575795-B2EE1271-AD22-4C79-85A0-84B5B9155EB0Q35584459-AE4924B2-1956-4F14-9346-35DE5657DAE5Q35807563-208598B1-75A0-44DA-A339-A73756B8B3AEQ36086314-3C7C5B9D-8C3D-4DEF-9499-BDDE374C0CA1Q36403699-36C70A34-FC19-47D4-BDD9-AC1E106B03E2Q36641490-CD22D29D-ADF6-43D9-BACD-874F02A858ECQ36894571-050ACC8E-04A2-4644-9679-E503721F37C9Q36984808-A51B5A42-A224-45B1-A01D-139D9CA839FAQ37334076-DBB8E6AC-6C34-4208-BFB2-B64ABCE0D2F8Q38156237-61EEF068-5091-4CDC-8A3D-40DE29A0DD4CQ38192711-68648C24-3E6D-4620-95E0-3A411BA29B65Q38214174-4CF6B76E-44D4-46F2-B08F-D68072F535B1Q38801087-DF3D541D-CFA4-4DFA-BAAE-66F523B180ADQ39043925-1EFB621E-8BC9-4FF6-A9B9-6DE96B5E53FBQ39223712-F4436700-F2C4-4527-B395-3F36D7755822Q41454605-359FC5BC-6DC3-4727-A88A-C0D7B50F7642Q42170001-D3DD6E37-F3AD-4BF4-AA4A-A74AFCFFAD53Q44775530-D7039B58-309A-4F2D-BD7D-128A3F409B54Q44880035-B9BF1EDD-A168-4D27-B330-166116EFDB81Q45715068-B793DF47-29AF-4DCE-B75D-E27C6D043218Q46032907-D33A0B96-A11F-4AA7-94FA-E654365C4C17Q46121131-8776D958-B6DC-4EC0-8BBD-F36A741AD8CDQ46716344-A46C7FA8-A78A-4DAE-87CD-7AB461061E77Q47604536-E9008CEF-884D-4B30-9DEB-1F54D9667FFDQ51088645-8FBD4648-CC00-4232-A37F-115624683DFBQ51093725-A30F098B-99A7-498E-AA82-DA553850FA32Q51990136-366E5755-F472-438A-A5B9-35005A9ED3CBQ52187166-05104DD7-61B9-4B31-BB84-192F67488730Q57435671-F2C69E44-B013-4453-8558-315A38CC5470
P2860
Prediction of clinical response to methylphenidate in children with attention-deficit hyperactivity disorder.
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
1995年论文
@zh
1995年论文
@zh-cn
name
Prediction of clinical respons ...... eficit hyperactivity disorder.
@en
type
label
Prediction of clinical respons ...... eficit hyperactivity disorder.
@en
prefLabel
Prediction of clinical respons ...... eficit hyperactivity disorder.
@en
P2093
P1476
Prediction of clinical respons ...... eficit hyperactivity disorder.
@en
P2093
Buitelaar JK
Swaab-Barneveld H
Van der Gaag RJ
P304
P356
10.1097/00004583-199508000-00012
P577
1995-08-01T00:00:00Z